Status:
UNKNOWN
Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Lead Sponsor:
GAAD Medical Research Institute Inc.
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Amyotrophic Lateral Sclerosis (ALS, sometimes called Lou Gehrig's s Disease, or Maladie de Charcot) is a progressive, usually fatal, neurodegenerative disease caused by the degeneration of motor neuro...
Detailed Description
As a motor neuron disease, ALS causes muscle weakness and atrophy throughout the body as both the upper and lower motor neurons degenerate, ceasing to send messages to muscles. Unable to function, the...
Eligibility Criteria
Inclusion
- Patients with ALS
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00673140
Start Date
May 1 2008
End Date
June 1 2010
Last Update
August 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Centre for Incurable Diseases
Toronto, Ontario, Canada, M4V 1L5